JOHANNESBURG (Reuters) – South Africa has suspended the rollout of Johnson & Johnson’s (J&J) COVID-19 vaccine, its health minister said on Tuesday, after U.S. federal…
Read More
Know the Enemy: Why Genetic Sequencing Is Key to Tracking COVID
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. In a typical year, the surveillance team at the University of…
Read More
France Extends Gap Between mRNA Vaccine Shots to Ramp-up Rollout
PARIS (Reuters) – France will lengthen the period between the first and second shots of mRNA anti-COVID vaccines to six weeks from four weeks as…
Read More
Study IDs Most Common Lingering Symptoms 8 Months After Mild COVID
Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center . Loss of smell, loss of taste, dyspnea, and fatigue are the four…
Read More
Several Vaccine Sites Pause Johnson & Johnson Shot After Adverse Reactions
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Several vaccine sites across the U.S. paused administration of the Johnson…
Read More
Neutral Zone Border-Crossing Parties Risking Infection
BLAINE, Wash. — In the shadows of covid travel restrictions, a 42-acre park on the far western edge of the U.S.-Canadian dividing line has become…
Read More
Norway Keeps AstraZeneca Vaccine on Hold for Another 3 Weeks
OSLO (Reuters) – Norway will delay its decision on whether to resume the use of AstraZeneca’s COVID-19 vaccine by up to three weeks, the Norwegian…
Read More
COVID Vaccine Hesitancy Could Mean More Deaths, Long Restrictions
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Even as millions of Americans flock to be vaccinated against COVID-19,…
Read More
Peru Hits New COVID Case Record as Brazilian Variant Spreads
LIMA (Reuters) – Peru said on Thursday it had confirmed a record high of 11,260 new cases of coronavirus in a single day amid a…
Read More
GSK and Vir Seek Emergency Use of COVID-19 Therapy in United States
(Reuters) – GSK and Vir Biotechnology have filed an application to U.S. regulators for emergency use authorization of their antibody therapy to treat early-stage COVID-19…
Read More